Shares of Mouwasat hit lifetime high

22/03/2022 Argaam Special

A hospital of Mouwasat Medical Services Co.


Shares of Mouwasat Medical Services Co. hit their highest level since listing at SAR 220, today, March 22.

 

The stock gained 7% to close at SAR 220, recording the highest close since listing. Nearly 164,800 shares exchanged hands.

 

Established in 1974, the company started as a sole proprietorship with SAR 100 million capital, to manage and operate medical facilities through setting up Mouwasat Clinic in Dammam in 1975.

 

The first comprehensive medical facility was established under the name, “Mouwasat Hospital”, in Dammam in 1984, with operations starting in 1988.

 

On Sept. 2, 2009, Mouwasat was listed on the Saudi Stock Exchange (Tadawul) at SAR 44 (before adjustment) or SAR 11 (after adjustment).

 

Mouwasat Stock Performance

Annual High (SAR)

220.00

Today, March 22, 2022

Annual Low (SAR)

136.40

March 23, 2021

Historical High (SAR)

220.00

Today, March 22, 2022

Historical Low (SAR)

12.90

Sept. 2, 2009 (Listing date)

Highest Traded Volume (mln shares)

35.78

Sept. 2, 2009 (Listing date)

 

 The following table shows the most important financial indicators of the company:

 

Key Financial Indicators

EPS (last 12 months) (SAR)

5.78

Operating P/E (last 12 months) (x)

38.06

Book Value (SAR)

26.04

P/B Ratio (x)

8.45

 

The company increased its capital twice through bonus shares in 2012 and 2018 to reach the current capital of SAR 1 billion.

 

Capital Amendments

Date

Method

Previous Capital (SAR mln)

New Capital (SAR mln)

Variation (%)

2018

Bonus shares

500

1000

+100%

2012

Bonus shares

250

500

+100%

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Most Read